289
Views
9
CrossRef citations to date
0
Altmetric
Original Article

Clinical Features, Treatment, and Visual Outcomes of Japanese Patients with Posterior Scleritis

, MD, , MD, , MD, , MD & , MD
Pages 209-216 | Received 22 Sep 2018, Accepted 23 Jan 2019, Published online: 26 Feb 2019
 

ABSTRACT

Purpose: The purpose of this study is to describe clinical features and visual outcomes of Japanese patients with posterior scleritis.

Methods: Clinical records of 10 patients (13 eyes) presenting between 2006 and 2016 were retrospectively reviewed.

Results: The mean age was 50.1 ± 20.8 years; 50% were women, and three patients had bilateral disease. Associated anterior scleritis (11 eyes, 85%) and serous retinal detachment (8 eyes, 62%) were common at presentation. Treatment consisted of corticosteroids (all patients) and immunosuppressive agents (seven patients). The mean subfoveal choroidal thickness was significantly reduced over follow-up [611 μm at baseline, 298 μm (p < 0.01) at 1 month, and 238 μm (p < 0.01) at 1 year]. Recurrent inflammation was observed in six patients. A best-corrected visual acuity of 0.8 or better was achieved in all 13 eyes at 3 years and 71% of eyes at 5 years.

Conclusion: Although 60% of patients with posterior scleritis had recurrence, visual outcomes were favorable.

Declaration of interests

The authors report no conflicts of interest. The authors alone are responsible for the content and writing of the paper.

Additional information

Funding

The authors received research funds relating to this study from Novartis and Mitsubishi Tanabe Pharma.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.